Terms: = Leukemia AND CD52, CDW52, EDDM5 AND Diagnosis
35 results:
1. T-Cell Prolymphocytic leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia.
Li K; Du Y; Cai Y; Liu W; Lv Y; Huang B; Zhang L; Wang Z; Liu P; Sun Q; Li N; Zhu M; Bosco B; Li L; Wu W; Wu L; Li J; Wang Q; Hong M; Qian S
Leukemia; 2023 Feb; 37(2):308-325. PubMed ID: 36543880
[TBL] [Abstract] [Full Text] [Related]
3. Subclones of bone marrow CD34
Jia R; Ji M; Li G; Xia Y; Guo S; Li P; Sun Y; Lu F; Zhang J; Zang S; Yan S; Ye J; Xue F; Ma D; Sun T; Ji C
Cancer; 2022 Nov; 128(22):3929-3942. PubMed ID: 36197314
[TBL] [Abstract] [Full Text] [Related]
4. Post-transplant lymphoproliferative disorder presenting as T-prolymphocytic leukemia: a case report.
Kasinathan G; Kori AN; Azmie NM
J Med Case Rep; 2019 Jul; 13(1):223. PubMed ID: 31327318
[TBL] [Abstract] [Full Text] [Related]
5. Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.
Loeff FC; Rijs K; van Egmond EHM; Zoutman WH; Qiao X; Kroes WGM; Veld SAJ; Griffioen M; Vermeer MH; Neefjes J; Frederik Falkenburg JH; Halkes CJM; Jedema I
Am J Hematol; 2019 Jan; 94(1):93-102. PubMed ID: 30370942
[TBL] [Abstract] [Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
[TBL] [Abstract] [Full Text] [Related]
7. [Successful treatment of large granular lymphocytic leukemia accompanied by refractory anemia with alemtuzumab].
Iijima K; Hirao M; Hino T; Kamoda Y; Iizuka H; Kida M; Hangaishi A; Usuki K
Rinsho Ketsueki; 2017; 58(12):2392-2396. PubMed ID: 29332872
[TBL] [Abstract] [Full Text] [Related]
8. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2017 Nov; 92(11):1243-1259. PubMed ID: 29044676
[TBL] [Abstract] [Full Text] [Related]
9. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
Hu Z; Li S; Medeiros LJ; Sun T
Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
[TBL] [Abstract] [Full Text] [Related]
10. Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients.
Vázquez L; Salavert M; Gayoso J; Lizasoaín M; Ruiz Camps I; Di Benedetto N;
Rev Esp Quimioter; 2017 Apr; 30(2):103-117. PubMed ID: 28198173
[TBL] [Abstract] [Full Text] [Related]
11. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
[TBL] [Abstract] [Full Text] [Related]
12. [Large granular lymphocytic leukemia. A rare disease with personalized treatment options].
Adamkovich N; Kispál M; Krenács L; Bagdi E; Borbényi Z
Orv Hetil; 2014 Mar; 155(11):414-9. PubMed ID: 24613776
[TBL] [Abstract] [Full Text] [Related]
13. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract] [Full Text] [Related]
14. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
[TBL] [Abstract] [Full Text] [Related]
15. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
[TBL] [Abstract] [Full Text] [Related]
16. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
[TBL] [Abstract] [Full Text] [Related]
17. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
[TBL] [Abstract] [Full Text] [Related]
18. Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives.
Jaksić O; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):309-13. PubMed ID: 20432765
[TBL] [Abstract] [Full Text] [Related]
19. Eosinophilic myeloid disorders: new classification and novel therapeutic strategies.
Gotlib J
Curr Opin Hematol; 2010 Mar; 17(2):117-24. PubMed ID: 20071982
[TBL] [Abstract] [Full Text] [Related]
20. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
Laros-van Gorkom BA; Huisman CA; Wijermans PW; Schipperus MR
Neth J Med; 2007 Oct; 65(9):333-8. PubMed ID: 17954952
[TBL] [Abstract] [Full Text] [Related]
[Next]